Predictions
Koninklijke Philips Electronics
Start price
Target price
Perf. (%)
€30.23
16.03.20
16.03.20
€40.00
04.11.21
04.11.21
35.28%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€42.80
02.03.20
02.03.20
-
04.11.21
04.11.21
-8.24%
05.11.21
05.11.21
Dexcom Inc.
Start price
Target price
Perf. (%)
€57.00
11.02.20
11.02.20
€78.75
04.11.21
04.11.21
137.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€101.30
10.08.19
10.08.19
€169.00
04.11.21
04.11.21
83.17%
05.11.21
05.11.21
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€87.10
05.05.19
05.05.19
€200.00
04.11.21
04.11.21
113.03%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€235.41
17.01.19
17.01.19
€419.00
04.11.21
04.11.21
67.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Align Technology
Start price
Target price
Perf. (%)
€194.93
27.11.18
27.11.18
€558.00
04.11.21
04.11.21
201.95%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€67.50
27.07.18
27.07.18
€110.00
04.11.21
04.11.21
174.89%
05.11.21
05.11.21
Align Technology
Start price
Target price
Perf. (%)
€289.85
11.10.18
11.10.18
€455.96
04.11.21
04.11.21
103.07%
05.11.21
05.11.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€222.00
01.02.21
01.02.21
€260.00
30.03.22
30.03.22
-6.17%
09.10.21
09.10.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Humana Inc.
Start price
Target price
Perf. (%)
€370.00
01.05.21
01.05.21
-
01.05.22
01.05.22
-5.65%
02.09.21
02.09.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Dexcom Inc.
Start price
Target price
Perf. (%)
€82.24
09.02.21
09.02.21
€87.50
09.02.22
09.02.22
29.20%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Higher risks for its business
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.83
08.02.21
08.02.21
€41.00
16.07.21
16.07.21
27.92%
16.07.21
16.07.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.97
12.11.20
12.11.20
€50.00
12.11.21
12.11.21
21.49%
13.07.21
13.07.21
Top 10 in its market
Small cyclical dependencies
Below average Management
Hologic Inc.
Start price
Target price
Perf. (%)
€56.50
20.10.20
20.10.20
€60.00
04.11.21
04.11.21
-11.63%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.60
29.04.21
29.04.21
€245.00
29.04.22
29.04.22
-10.43%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€43.81
27.02.20
27.02.20
€58.00
04.11.21
04.11.21
0.70%
03.06.21
03.06.21
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€416.00
06.02.21
06.02.21
-
06.02.22
06.02.22
7.91%
25.05.21
25.05.21
EBIT growth >5% per year expected
Very low/no dividend yield expected
Abiomed Inc.
Start price
Target price
Perf. (%)
€177.80
01.12.19
01.12.19
€300.00
04.11.21
04.11.21
49.94%
29.04.21
29.04.21
Could be worthwhile Investment >10% per year
Teleflex Inc.
Start price
Target price
Perf. (%)
€320.00
21.02.21
21.02.21
-
21.02.22
21.02.22
14.38%
23.04.21
23.04.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected